Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-178145
Filing Date
2015-05-08
Accepted
2015-05-08 06:06:30
Documents
9
Effectiveness Date
2015-05-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A d922562ddefa14a.htm DEFA14A 53868
2 GRAPHIC g922562dsp002a.jpg GRAPHIC 17296
3 GRAPHIC g922562dsp002c.jpg GRAPHIC 60451
4 GRAPHIC g922562dsp002d.jpg GRAPHIC 12102
5 GRAPHIC g922562dsp003a.jpg GRAPHIC 14988
6 GRAPHIC g922562dsp003b.jpg GRAPHIC 11972
7 GRAPHIC g922562dsp004.jpg GRAPHIC 50205
8 GRAPHIC g922562dsp004b.jpg GRAPHIC 12007
9 GRAPHIC g922562dsp005.jpg GRAPHIC 10526
  Complete submission text file 0001193125-15-178145.txt   317284
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30171 | Film No.: 15844334
SIC: 2836 Biological Products, (No Diagnostic Substances)